RNA - Company ID 0001599901
The table below shows Avidity Biosciences, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $382.52M | $219.87M | $185.08M | $340.40M | $320.45M | $321.46M |
| Short-term investments | - | - | - | - | $85.09M | $6.68M |
| Receivables | - | $0.00 | $1.10M | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.80B |
| $1.54B |
| $611.31M |
| $622.94M |
| $411.14M |
| $331.68M |
| Property, plant & equipment | $23.33M | $12.67M | $8.38M | $6.25M | $4.80M | $1.47M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.96B | $1.56B | $628.55M | $638.80M | $427.58M | $333.90M |
| Accounts payable | $12.40M | $8.46M | $8.81M | $4.64M | - | - |
| Total current liabilities | $195.45M | $98.02M | $80.68M | $51.91M | $29.66M | $14.59M |
| Long-term debt | - | - | - | - | - | $1.77M |
| Total liabilities | $269.45M | $138.94M | $127.79M | $60.73M | $46.15M | $27.68M |
| Retained earnings | -$1.58B | -$893.07M | -$570.76M | -$358.54M | -$184.55M | -$66.54M |
| Total equity | $1.69B | $1.42B | $500.76M | $578.08M | $381.43M | $306.22M |